Global importers, wholesalers, hospitals, specialty pharmacies, distributors, and NGOs require reliable sourcing partners who can ensure uninterrupted access to critical neurology therapies.
As a trusted pharmaceutical export company, Ikris Pharma Network has emerged as a reliable Neurology Medicine Supplier from India. The company supports the critical global need for high-quality neurology medicines sourced directly from leading Indian manufacturers and approved supply channels.
Whether you are a global pharmaceutical importer, wholesaler, supplier, distributor, hospital procurement team, specialty pharmacy, or NGO, choosing the most trusted Neurology Medicine Supplier from India is important for improving access to specialty neurological treatments for disorders of the nervous system.
Industry Statistics & Market Insights:
In recent years, the global burden of neurological conditions has increased. The demand for advanced neurology medicines and reliable pharmaceutical supply chains is growing with it.
As per WHO and the Global Burden of Disease (GBD) Study 2021, published in The Lancet Neurology in 2024, neurological disorders are the primary contributor to the global disease burden, affecting approximately 43% of the world's population, nearly 3.4 billion people.
Recent global data indicate:
Key industry facts include:
These key factors make India a preferred place for sourcing neurology medicines, neurodegenerative disease therapies, rare disease medicines, and specialty pharmaceuticals.
India's pharmaceutical export industry is vast and known for offering several advantages:
Ikris Pharma Network (IPN) is known for supporting global pharmaceutical importers, wholesalers, suppliers, distributors, hospital procurement teams, specialty pharmacies, or NGOs through:
As a trusted Neurology Medicine Supplier and Exporter from India, we provide quality, compliance, and continuous access to specialty neurology therapies.
Who We Support:
Ikris Pharma Network supports pharmaceutical importers, wholesalers, suppliers, distributors, hospital procurement teams, specialty pharmacies, or NGOs worldwide, including:
Our reliable sourcing and supply capabilities meet the requirements of both regulated and semi-regulated markets worldwide.
Recent therapeutic drugs approved by leading regulatory authorities such as the US FDA and EMA have expanded treatment options for neurological conditions. We help facilitate access to neurology medicines, including therapies used in the treatment of:
Availability of these therapeutic drugs is subject to country regulations, product sourcing, and applicable pharmaceutical requirements.
Epilepsy & Seizure Disorders: Access to first-line and specialty antiepileptic medicines, including therapies for rare and refractory epilepsies.
Access to disease-modifying therapies and specialty immunological treatments.
Access to acute and preventive migraine therapies, including CGRP-targeted treatments.
Therapies for diabetic neuropathy and other chronic neuropathic pain conditions.
Support for therapies used in rare and orphan neurological conditions through the Named Patient Program (NPP).
Global importers, wholesalers, suppliers, NGOs, and hospitals choose Ikris Pharma Network because of:
These strengths help make us one of the most trusted Neurology Medicine Suppliers from India.
World Health Organization (WHO) – Neurological Disorders and Global Health Statistics
The Lancet Neurology – Global Burden of Disease Study 2021 (published 2024)
Institute for Health Metrics and Evaluation (IHME) – Global Burden of Disease Data
U.S. Food and Drug Administration (FDA) – Neurology Drug Approvals
European Medicines Agency (EMA) – Neurology and CNS Medicines